You are here

Home » Content

Prenatal tanıda Konya populasyonuna ait üçlü tarama testi sonuçları

Triple test of population of Konya in prenatal diagnosis

Journal Name:

  • Selçuk Tıp Dergisi

Publication Year:

  • 2001

Key Words:

Keywords (Original Language):

Author NameUniversity of Author
Abstract (2. Language): 
İn this study, a MoM value were calculated for the triple test at 16-20 weeks of pregnancies. The aim of this investigation was to help diagnosis of Down syndrome and neural tube defect Median levels of these three analyt were calculated for 16-20 vveeks of pregnancy These values were combined with age and individual risk values were determined. As a result of this investigation triple test ıs acheupreliable and ımportant tecnique for detection of NTD and Down syndrome and must be used generally.
Bookmark/Search this post with
Abstract (Original Language): 
Bu araştırma Konya ilinde 16-20. gebelik haftalartndaki hamilelerde üçlü tarama testi için bir ortalama median değer (MoM-multiple of median) belirleyip, Down Sendromu ve NÖral Tüp Defektlerinin prenatal olarak tanınmasına yardımcı olmak amacıyla planlandı. Çalışma grubuna dahil edilen tüm gebelerin 16.-20. gebelik haftalarında her üç analit için maternal serum düzeylerinin median değerleri hesaplandı. Bu değerler yaş ile kombine edilerek bireysel risk değerine ulaşıldı. Sonuç olarak, üçlü testin kolay ve ucuz olması, tüm toplumlarda NTD ve Down sendromu taramasında önemli bir gösterge olması, ayrıca defektlerin saptanması ve gebeliğin devamı hakkında fikir verebilmesi nedeniyle yaygın olarak kullanılması gereken noninvaziv bir test olduğu kanısına varıldı.
FULL TEXT (PDF): 
PDF icon arastirmax-prenatal-tanida-konya-populasyonuna-ait-uclu-tarama-testi-sonuclari.pdf
  • 3
153-158
  • Turkish

REFERENCES

References: 

1. Brock DJ Sutcliffe RG. Alpha-fetoprotein in the an-lenatal diagnosis of anencephaiy and spina bifida. Lancet 1972; 29;2:197
2. Merkatz İR, Niîowsky HM, Macri JN, Johnson WE. An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities . Am J Obstet Gynecol 1984 ; 1 ;148(7):886-94
3. Bogard MH, Pandian MR, Jones OW. Abnormal ma¬ternal serum chorionic gonadotropin levels in preg-nancies with fetal chromosome abnormalities. Prenat Diagn 1987 ; 7(9):623-30.
4. Canick JA , Knıght GJ, Polamaki GE, Haddow JE, Cuckle HS, Wald NJ. Low second trimester maternal serum unkonjugated oestriol in pregnancies with Down syndrome. Br J Obstet Gynaecol 1988; 95 (4): 330-3
5. Wald N , Cuckle H Antenatal screenıng for Down syndrome. Lancet 1988; 10;2:1362
6. Norgard -Petersen B, Larsen SO, Arends J, Svens-trup B, Tabor A Maternel serum markers in screenıng for Down syndrome. Clın Genet, 1990; 37:35-43
7. Keliner HL, VVeiner Z, VVeiss RR, Neuer M, Martin GM, Mueenuddİn M, Bombard A. Triple marker (a-fetoprotein, unconjugated estriol, Human choriconic gonadotropin) versus _afetoprotein plus free-psubunit in second -trimestr maternal serum screenıng for fetal Down syndrome ;A prospective comparîsion study. AM J ObStetrıc Gynecology 1995; 173:1306-9
8.. Barkai G, Goldman B, Ries L, Chaki R, Cuckle H. Ef-fect of gravidity on maternal serum markers for Down syndrome. Prenatal Diagnosis 1996; 16:319-22
9. Bogard MH, Jones OW, Felder RA, Best RG, Bradley L, Butts W, Crandall B, Macmahon W, Wians FH, Loeh PV. Prospective evaluation of maternal serum human chorionic gonadotropin levels in 3428 preg¬nancies. AM J Obstetric Gynecol 1991;165:663-7
10. Rose NC, Mennuti MT. Maternal serum screening for Neural Tu be Defects and fetal chromosome ab-normalities. West J Med 1993; 159:312-7
11. Owen J, Wenstrom KD, Hardin MJ, Boots LR, Hsu CC, Cosper PC, Dubard MB. The utility of fetal bi-ometry as an adjunct to the multiple-marker screening test for Down syndrome. AM J Obstet Gynecol 1994; 171:1041-6
12. Polamaki GE, Knİght GJ, McCarthy J, Haddow JE. Maternal serum screening for fetal Down's syndrome in the United States:A 1992 survey. AM J Obstet Gynecol 1993;169: 1558-62
13. Thornton G, Richard SV, Williams J, Holding S. Cli-nical experience with the triple test for Down:s syndro¬me screening. J Perinat Med 1991; 19:151-4
14. Aydınlı K. Prenatal tanıda noninvaziv yöntemler. Pre¬natal tanı ve tedavi 1992; 5:40-51

15. Wald NJ, Cuckle HS, Densem JW, Kennard A, Smith D. Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal vveight. Fetal and Neonatal Medicine 1992; 99:144-9
16. Macri JN, Spencer K, Anderson RW, Cook EJ. Free $ -choronic gonadotropin :a cross-reactivity study of two immunometric assays used in prenatal maternal serum screening for Down's syndrome. Ann Cfin Bi-OChem 1993; 30:94-8
17. Wald NJ, Watt HC. Serum markers for Down's syndrome ın relatıon to number of prevıous bırths and maternal age. Prenatal diagnosis 1996; 16:699-703
18. Muller F, Bussieres L. Maternal serum markers for fetal trısomy 21 screening. Europan J Obst. Gynecol 1996; 65:3-6
19. Polamaki GE, Knight GJ, McCarthy J, Haddow JE, Donhowe JM. Maternal serum screening for fetal Down's syndrome in the United States:A 1995 survey. AM J Obstet Gynecol 1997; 176:1046-51
20. Elias S, Simpson JL. Maternal serum screening for fetal genetıc dısorders. 1992
21. Benn PA, Borgida A, Horne D, Briganti BS, Collins R, Rodis JF, Dovvn syndrome and neural tube defect screening: The value of using gestational age by ult-rasonography. AM J Obstet Gynecol 1997; 176:1056¬61
22. Kabukcu A, Önderoğlu L, Durukan T, Laleli Y. ikinci trimesterde anne serumunda açıklanamayan al-fafetoprotein yüksekliğinin gebeliğin sonucuna etkisi. T- Klın Jınekol Obst 1996; 6:287-9
23. Thiagarajafı S, Stround CB, Vavelidis F, Schnorr JA, Schnatterly TP, Ferguson JE. Elevated maternal serum _afeto protein levels:What is the risk of fetal aneuploidy? AM J Obstet Gynecol 1995; 173:388-92
24. Benn PA, Horne D, Briganti BS, Greenstein RM. Pre¬natal diagnosis of diverse choromosome abnormalites population of patients identified by triple marker tes-ting a screen posilive for Down syndrome. Am J Obs¬tet Gynecol 1995; 173 (2):496-501
25. Santolaya J, Jessup BS, Burd Ll, Prins GS, Burton K. Pregnancy Outcome in women with low midtrimester maternal Serum unconjugated estriol. J Reprod Med 1996;41:87-90
26. Morsınk LP, Sikkema-Raddatz B, Beekhuıs JR, De-Wolf BT, Mantıng A. Placental mosaıcism ıs as¬sociated with unexplained second-trimestr elevatîon of MShCG levels but not with elevation MSAFP le¬vels. Prenatal Diagnosis 1996;16(9):845-51

Thank you for copying data from http://www.arastirmax.com